Latest filing published 09 Mar 2023 for Accelerate Diagnostics, Inc.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark C. Miller: trading record in brief
Mark C. Miller, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Stericycle Inc, Accelerate Diagnostics, Inc and Ventana Medical Systems Inc. In total, 265 filings cover trades dated from 17 March 2006 to 7 March 2023.
The open-market side counts 1 purchase for €740k alongside 114 sales for €159.9M. Sales outweigh purchases by €159.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 22 share grants and 106 option exercises.
Most recently, on 9 March 2023, the filings show an option exercise in Accelerate Diagnostics, Inc. The latest purchase dates back some time: it was published 6,603 days ago, on 10 October 2008. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark C. Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,396 shares0Common StockSEC:0001628280-23-007310:1
- 50,886 shares0Common StockSEC:0001628280-23-007310:0
- 13,022 shares@ US$7.68100.0% of flowCommon StockSEC:0001628280-21-024837:0
- 13,020 shares@ US$7.6833.2% of flowCommon StockSEC:0001628280-21-006837:0
- 13,020 shares@ US$7.6832.7% of flowCommon StockSEC:0001628280-21-002822:0
- 132,030 shares@ US$51.5514.8% of flowCommon StockSEC:0001692742-19-000080:0
- 132,030 shares@ US$57.3016.5% of flowCommon StockSEC:0001692742-19-000080:1
- 42,253 shares@ US$51.554.7% of flowCommon StockSEC:0001692742-19-000080:2
- 42,253 shares@ US$57.305.3% of flowCommon StockSEC:0001692742-19-000080:3
- 20,000 shares@ US$51.202.2% of flowCommon StockSEC:0001692742-19-000080:4
- 20,000 shares@ US$57.302.5% of flowCommon StockSEC:0001692742-19-000080:5
- 66,031 shares@ US$51.557.4% of flowCommon StockSEC:0001692742-19-000080:6
- 66,031 shares@ US$56.828.2% of flowCommon StockSEC:0001692742-19-000080:7
- 374 shares@ US$45.560.0% of flowCommon StockSEC:0001692742-19-000028:1
- 1,079 sharesCommon StockSEC:0001692742-19-000028:0
- 94 shares@ US$45.000.0% of flowCommon StockSEC:0001692742-19-000019:1
- 270 sharesCommon StockSEC:0001692742-19-000019:0
- 31,115 shares@ US$46.832.6% of flowCommon StockSEC:0001692742-18-000107:0
- 31,115 shares@ US$65.043.6% of flowCommon StockSEC:0001692742-18-000107:1
- 34,199 shares@ US$46.832.8% of flowCommon StockSEC:0001692742-18-000107:2
- 34,199 shares@ US$65.123.9% of flowCommon StockSEC:0001692742-18-000107:3
- 64,551 shares@ US$46.835.3% of flowCommon StockSEC:0001692742-18-000104:0
- 64,551 shares@ US$65.057.4% of flowCommon StockSEC:0001692742-18-000104:1
- 30,676 shares@ US$46.832.5% of flowCommon StockSEC:0001692742-18-000104:2
- 30,676 shares@ US$65.053.5% of flowCommon StockSEC:0001692742-18-000104:3
25 of 249 declarations
